Revolution Medicines is a late-stage clinical oncology company focused on developing targeted therapies for patients with RAS-addicted cancers. Our innovative R&D pipeline features RAS(ON) inhibitors tailored to suppress various oncogenic variants of RAS proteins, setting us apart in the fight against difficult-to-treat cancers.
No jobs found. Subscribe below to get notified when we find something for you.
Searching